U.S. Metals and Mining Stock News

NYSE:UCB
NYSE:UCBBanks

United Community Banks (UCBI) Margin Improvement Reinforces Bullish Profitability Narrative

United Community Banks (UCBI) opened 2026 with Q1 total revenue of US$265.7 million and basic EPS of US$0.69, while trailing twelve month revenue stood at US$1.0 billion and EPS at US$2.74. This gives investors a clear read on both the latest quarter and the broader run rate. Over the past few quarters, revenue has moved from US$232.3 million in Q1 2025 to US$265.7 million in Q1 2026 and EPS has shifted from US$0.58 to US$0.69, with trailing net income rising from US$244.6 million in Q4 2024...
NasdaqGS:CLBK
NasdaqGS:CLBKBanks

Columbia Financial (CLBK) Net Interest Margin At 2.42% Tests Bullish Growth Narratives

Columbia Financial (CLBK) opened 2026 with Q1 revenue of US$66.2 million and basic EPS of US$0.13, anchored by net income of US$13.1 million. This puts fresh numbers behind the company’s recent return to profitability. The business has seen revenue move from US$55.9 million and EPS of US$0.09 in Q1 2025 to US$66.2 million and EPS of US$0.13 in Q1 2026, with trailing twelve month EPS at US$0.55 as the earnings base rebuilds. With a Q1 net interest margin of 2.42% and a cost to income ratio of...
NYSE:O
NYSE:ORetail REITs

Realty Income Expands In Europe As Apollo Partnership Supports Growth

Realty Income (NYSE:O) is highlighting Europe as a key growth engine, with about one fifth of its rent now coming from 618 properties across the region. The company has entered into a $1b partnership with Apollo to support additional acquisitions in international net lease markets. This arrangement is designed to expand Realty Income's access to capital while targeting growth that does not rely on stretching returns. Realty Income, a large net lease real estate investment trust, focuses on...
NYSE:COSO
NYSE:COSOBanks

CoastalSouth Bancshares (COSO) Net Interest Margin Holds At 3.59% Reinforcing Bullish Profitability Narratives

CoastalSouth Bancshares (COSO) opened 2026 with Q1 total revenue of US$21.3 million and basic EPS of US$0.53, supported by net income of US$6.3 million. Over recent quarters, total revenue has moved from US$18.0 million in Q1 2025 to US$21.3 million in Q1 2026, while quarterly EPS has ranged from US$0.49 to US$0.60 across that period. This provides a clearer view of how the income statement is scaling. With a trailing net profit margin of 31.6% holding steady and a net interest margin of...
NasdaqGS:NXPI
NasdaqGS:NXPISemiconductor

Is It Too Late To Consider NXP Semiconductors (NXPI) After A 31% One-Year Rally?

If you are wondering whether NXP Semiconductors at around US$224.50 is priced attractively or asking too much, the valuation picture is the key place to focus. The stock has recorded returns of 7.0% over the last 7 days, 17.3% over 30 days, 1.5% year to date, and 31.0% over the past year, which naturally raises questions about what is already reflected in the share price. Recent coverage has centered on NXP Semiconductors as part of broader conversations about semiconductor names and their...
NasdaqGS:CCNE
NasdaqGS:CCNEBanks

CNB Financial (CCNE) Net Interest Margin Holds At 3.84% Testing Bullish Earnings Narratives

CNB Financial (CCNE) has just reported Q1 2026 results, with revenue of about US$82.3 million and basic EPS of US$0.88 setting the tone for the quarter, backed by trailing twelve month revenue of US$300.3 million and EPS of US$2.87. Over recent periods the company has seen revenue move from US$56.4 million in Q4 2024 to US$55.4 million in Q1 2025, then to US$82.3 million in Q1 2026. Quarterly EPS shifted from US$0.66 to US$0.50 and now US$0.88, giving investors a clearer view of how the...
NasdaqGS:SFNC
NasdaqGS:SFNCBanks

Is Simmons First National (SFNC) Pricing Reflect Its Recent 1 Year Share Price Strength

Wondering if Simmons First National at US$21.22 is giving you genuine value or just looks cheap on the surface? This article breaks down what the current share price might be implying about the company. The stock shows returns of 3.2% over 7 days, 12.0% over 30 days, 12.8% year to date and 23.7% over 1 year, while the 5 year figure sits at an 11.4% decline and the 3 year return is 56.3%. Recent attention around Simmons First National has focused on its share price performance and how it...
NYSE:RSG
NYSE:RSGCommercial Services

Republic Services AI Upgrade At Peabody Center And What It Means For RSG

Republic Services (NYSE:RSG) has opened an upgraded Peabody Recycling Center in Massachusetts. The facility features advanced AI powered technology aimed at improving recycling efficiency and processing capacity. The revamped site supports regional waste reduction efforts and reflects the company’s focus on technology driven operations. For investors tracking NYSE:RSG, this move fits squarely within Republic Services’ core role as a recycling and waste management operator. The company is...
OTCPK:WCCB
OTCPK:WCCBBanks

West Coast Community Bancorp (OTCPK:WCCB) Net Margin Strength Reinforces Bullish Narratives

West Coast Community Bancorp (WCCB) has opened Q1 2026 with total revenue of US$37.2 million and basic EPS of US$1.45, setting a clear earnings tone for the new year. Over recent quarters, revenue has moved from US$27.0 million in Q4 2024 to US$32.8 million in Q1 2025 and US$37.2 million in Q1 2026, while quarterly basic EPS has shifted from US$0.37 to US$1.17 and then to US$1.45, giving investors a concrete view of how the top and bottom lines have tracked together. With a trailing 12 month...
NasdaqGS:REGN
NasdaqGS:REGNBiotechs

Sanofi’s Lunsekimig Data Put Focus On Regeneron’s Immunology Exposure Beyond Dupixent

Regeneron Pharmaceuticals (NasdaqGS:REGN) reported positive Phase 2 results for lunsekimig, a bispecific antibody, in moderate to severe asthma and chronic rhinosinusitis with nasal polyps. The company said lunsekimig met primary and key secondary endpoints in both indications. The data mark one of the first major readouts from Regeneron’s next generation immunology pipeline beyond Dupixent. Regeneron focuses on biologic therapies in immunology and other specialty areas, with Dupixent as a...
NasdaqGS:TSCO
NasdaqGS:TSCOSpecialty Retail

Tractor Supply (TSCO) Net Margin Slippage Tests Bullish Growth Narrative In Q1 2026

Tractor Supply (TSCO) opened 2026 with Q1 revenue of US$3.6b and basic EPS of US$0.31, alongside net income of US$164.5m, setting the tone for how the year is starting to shape up. The company reported revenue of US$3.5b and EPS of US$0.34 in Q1 2025, compared with US$3.6b and EPS of US$0.31 in Q1 2026. Trailing twelve month revenue sits at US$15.6b and EPS at US$2.05, giving you a clearer read on how margins are holding up through different seasons. See our full analysis for Tractor...
NasdaqGS:RBB
NasdaqGS:RBBBanks

RBB Bancorp (RBB) Earnings Rebound And 28.1% Margin Test Bearish Profitability Narrative

RBB Bancorp (RBB) has just wrapped up Q1 2026 with a recent run of quarterly numbers that includes Q4 2025 total revenue of US$31.7 million and net income of US$10.2 million, equivalent to basic EPS of about US$0.60, against a trailing twelve month revenue base of US$113.6 million and net income of US$31.9 million. Over the past year, the company has seen quarterly revenue move from US$22.7 million in Q4 2024 to US$31.7 million in Q4 2025, while basic EPS over that span stepped from US$0.25...
NasdaqGS:ZS
NasdaqGS:ZSSoftware

Zscaler Award Puts Google Cloud Recognition Against Weak Share Performance

Zscaler has been named the 2026 Google Cloud Partner of the Year for Security in the Application category. The recognition highlights Zscaler’s role in AI security within the Google Cloud ecosystem. The award adds fresh industry validation to Zscaler’s position in the cybersecurity market. Zscaler (NasdaqGS:ZS), trading at $139.61, is getting fresh attention after being recognized by Google Cloud as its 2026 Partner of the Year for Security in the Application category. The stock has seen a...
NYSE:GEV
NYSE:GEVElectrical

Is It Too Late To Consider GE Vernova (GEV) After Its 205% One Year Surge?

Investors may be wondering whether GE Vernova's share price still offers value after a strong run, or if most of the easy gains are already on the table. The stock last closed at US$991.30, with returns of 0.4% over 7 days, 16.5% over 30 days, 45.9% year to date, and 204.7% over the past year, which can change how investors think about both opportunity and risk. Recent coverage has focused on GE Vernova as a newly listed, pure play power and energy transition business and how the stock has...
OTCPK:CSBB
OTCPK:CSBBBanks

CSB Bancorp (OTCPK:CSBB) Loan Growth With Lower Non Performing Loans Challenges Risk Concerns

CSB Bancorp (CSBB) has put up a clean set of numbers for Q1 2026, with Q4 2025 revenue at US$9.5 million, basic EPS at US$0.71, and net income of US$1.9 million anchoring the latest run of results against a trailing year where earnings grew 33.5% and net profit margin sat at 30.2%. Over recent quarters, revenue has moved from US$9.1 million in Q4 2024 to US$11.0 million in Q1 2025, US$11.5 million in Q2 2025, US$12.3 million in Q3 2025, then US$9.5 million in Q4 2025, with EPS shifting from...
NYSE:ALK
NYSE:ALKAirlines

Alaska Air Group (ALK) Q1 Loss Of US$193m Tests Bullish Margin Expansion Narrative

Alaska Air Group (ALK) has opened 2026 with Q1 revenue of US$3.3b and a basic EPS loss of US$1.69, compared with a trailing twelve month basic EPS of US$0.63 on revenue of US$14.4b that produced net income of US$73m. Over recent quarters, revenue has moved from US$3.1b in Q1 2025 to US$3.6b in Q4 2025 before landing at US$3.3b in the latest period. Quarterly EPS has swung from a loss of US$1.35 in Q1 2025 to a profit of US$1.45 in Q2 2025 and back to a loss in Q1 2026, leaving investors...
NasdaqGS:NTRS
NasdaqGS:NTRSCapital Markets

Northern Trust (NTRS) Margin Compression To 20.7% Tests Bullish Efficiency Narrative

Northern Trust (NTRS) has opened Q1 2026 earnings season with a recent run of quarterly results that show total revenue moving from US$1,960.5 million in Q3 2024 to US$2,131.1 million in Q4 2025, alongside quarterly EPS stepping up from US$2.23 to US$2.44 over the same period. Over the last reported trailing twelve months to Q1 2026, revenue has ranged between US$7.9 billion and US$8.6 billion, with EPS running between about US$8.5 and US$10.8. This provides a basis for investors to weigh...
NYSE:MMM
NYSE:MMMIndustrials

3M (MMM) Margin Compression Reinforces Bearish Earnings Narrative Heading Into Q1 2026

3M (MMM) has just opened its Q1 2026 reporting season conversation with a recent run of results that saw quarterly revenue range from US$5.95 billion to US$6.52 billion through 2025, alongside basic EPS moving between US$1.08 and US$2.05 as net income fluctuated from US$577 million to US$1.12 billion. Over the same stretch, revenue has moved from US$6.01 billion in Q4 2024 to US$6.13 billion in Q4 2025, while basic EPS shifted from US$1.34 to US$1.08. This sets a backdrop where investors are...
NasdaqGS:BOKF
NasdaqGS:BOKFBanks

BOK Financial (BOKF) Net Margin Strengthens Community Narrative Of High Quality Earnings

BOK Financial (BOKF) opened 2026 with Q1 revenue of US$553.8 million and basic EPS of US$2.59, while trailing twelve month revenue sat at US$2.23 billion and EPS at US$9.88. This provides a clear snapshot of the bank's recent earnings power. Over the past year, revenue has moved from US$2.03 billion to US$2.23 billion and trailing twelve month EPS has gone from US$8.14 to US$9.88, giving investors a cleaner read on how the income statement is scaling. With net income on a trailing basis at...
NYSE:RTX
NYSE:RTXAerospace & Defense

RTX (RTX) Net Margin Expansion Tests Bullish Earnings Narrative Heading Into Q1 2026

RTX (RTX) opened the new year with Q1 2026 results coming on the heels of Q4 2025 revenue of US$24.2b and basic EPS of US$1.21, supported by Q4 net income of US$1.6b. Over the last six reported quarters, revenue moved from US$21.6b in Q4 2024 to US$24.2b in Q4 2025, while quarterly basic EPS ranged from US$1.10 to US$1.43. This sets up trailing twelve month EPS of US$5.02 and net income of US$6.7b as the reference point for today’s update, so the focus now is on how Q1 margins held up against...
NYSE:HAL
NYSE:HALEnergy Services

Halliburton (HAL) Net Margin Compression Challenges Bullish Earnings Growth Narratives

Halliburton (HAL) has just opened its books on the latest period, with trailing 12 month revenue most recently sitting at about US$22.2b and basic EPS shifting from US$2.84 a year ago to US$1.50 on the most recent trailing view, setting a very different earnings backdrop for investors to interpret. Over the last reported quarters, quarterly revenue has moved between US$5,417m and US$5,697m while basic EPS has ranged from US$0.02 to around US$0.70, giving a wide spread of earnings outcomes...
NasdaqGS:MBWM
NasdaqGS:MBWMBanks

Mercantile Bank (MBWM) Net Interest Margin Holds Near 3.5% Reinforcing Profitability Narratives

Mercantile Bank (MBWM) just posted another quarter of steady profitability, with Q4 2025 revenue at US$61.8 million and net income of US$22.8 million, which translates into basic EPS of US$1.40 ahead of its Q1 2026 reporting period. Over recent quarters the bank has seen revenue move from US$56.3 million in Q4 2024 to US$61.8 million in Q4 2025, while basic EPS increased from US$1.22 to US$1.40, giving investors a clear picture of consistent earnings power heading into the new year. With...
NasdaqGS:FRMI
NasdaqGS:FRMISpecialized REITs

Fermi (FRMI) Is Up 5.5% After Leadership Restructuring And New Texas Hubs Commitment - Has The Bull Case Changed?

Fermi Inc. recently reshaped its leadership and governance, with co-founder Toby Neugebauer stepping down as CEO, Miles Everson resigning as CFO to join the board, the creation of an interim Office of the CEO led by Co-Presidents Jacobo Ortiz Blanes and Anna Bofa, and the appointment of Jeffrey S. Stein as a new director, while also committing to new headquarters in Dallas and expanded offices at Project Matador in Amarillo. Together, these moves mark a shift from founder-led management to a...
NYSE:OGN
NYSE:OGNPharmaceuticals

Organon (OGN) Is Up 8.4% After VTAMA Wins Key Steroid-Free Role In New Pediatric Guidelines

On April 15, 2026, Organon & Co. reported that VTAMA (tapinarof) cream received a strong, evidence-based recommendation in the American Academy of Dermatology’s first pediatric atopic dermatitis guidelines, which recognize it as the only steroid-free topical supported by high-certainty evidence for children aged 2 and older across all disease severities. This endorsement strengthens VTAMA’s clinical profile in a large pediatric eczema population, potentially reinforcing Organon’s...